The global spine biologics market is expected to grow at a compound annual growth rate of 4.09 percent from 2018 to 2022, according to a 360 Market Updates report.
Key vendors in the spine biologics market include:
1. Alphatec Spine
2. Globus Medical
3. Medtronic
4. NuVasive
5. AlloSource
6. Amendia
7. ChoiceSpine
8. DePuy Synthes
9. Exactech
10. Harvest Technologies
More articles on biologics:
3 things to know about Lattice Biologics
8 key surgeon Q&As on biologics in orthopedics & spine
International Stem Cell Corp. to launch joint supplement for osteoarthritis pain in Q3 2018